{"id":50067,"date":"2022-10-25T22:01:48","date_gmt":"2022-10-25T20:01:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/"},"modified":"2022-10-25T22:01:48","modified_gmt":"2022-10-25T20:01:48","slug":"endoluxe-joins-nvidia-inception","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/","title":{"rendered":"Endoluxe Joins NVIDIA Inception"},"content":{"rendered":"
\n

MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Endoluxe today announced it has joined NVIDIA Inception<\/a>, a program designed to support startups revolutionizing industries with artificial intelligence.\n<\/p>\n

<\/a><\/p>\n

\nEndoluxe\u2019s first product \u2014 used in minimally invasive surgery \u2014 is a completely wireless endoscopic camera system platform with an onboard light source. The Endoluxe Vision system leverages powerful hardware at the edge to provide AI-powered clinical insights that can support clinicians and lead to better patient outcomes.\n<\/p>\n

\nNVIDIA Inception will allow Endoluxe to access NVIDIA\u2019s array of medical vision technology, helping drive the company\u2019s clinical decision support using edge computing. The program will also offer Endoluxe the opportunity to collaborate with industry-leading experts and other AI-driven organizations using NVIDIA technology.\n<\/p>\n

\n\u201cWe are honored to be accepted into the NVIDIA Inception program,\u201d said Dr. Neal Patel, Endoluxe Cofounder and Chief Innovation Officer. \u201cNVIDIA is a world leader in artificial intelligence, and it will be incredibly beneficial to work with their medical imaging and healthcare AI offerings and services to build out Endoluxe\u2019s surgical intelligence platform. We are especially excited to join the group of surgical visualization companies using the NVIDIA Clara Holoscan platform. It is the perfect choice to power artificial intelligence in our unique surgical visualization system.\u201d\n<\/p>\n

\n\u201cWhen I had the opportunity to see Endoluxe\u2019s technology, I immediately recognized the benefits that NVIDIA Inception would offer. Endoluxe is building an innovative visualization platform with clinical decision support that will greatly benefit from the NVIDIA portfolio,\u201d said Tom Calef, CTO of Activ Surgical. Activ Surgical, which has had great success in the NVIDIA Inception program, is focused on enabling a future of augmented reality and artificial intelligence-driven surgery that is safe, smart and accessible to all.\n<\/p>\n

\nNVIDIA Inception helps startups during critical stages of product development, prototyping and deployment. Every NVIDIA Inception member gets a custom set of ongoing benefits, such as NVIDIA Deep Learning Institute<\/a> credits, marketing support and technology assistance, which provides startups with the fundamental tools to help them grow.\n<\/p>\n

\nAbout Endoluxe<\/b>\n<\/p>\n

\nEndoluxe is a world-class endoscopic video imaging organization based in the United States, with worldwide distribution of its medical industry design award-winning Endoluxe Orb. The company is focused on reducing costs of legacy video platforms, enhancing procedure adoption and improving patient outcomes through better therapy application. Endoluxe is committed to being a vendor-agnostic platform that allows customers to utilize their existing investment in traditional scopes and supporting devices \u2014 while taking advantage of future technological advancements using our portable, integrated and feature-laden platform at 1\/4th the cost of legacy products. More information can be found at Endoluxe.com<\/a>.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nEndoluxe, Inc.
\n
Devon Bream, CEO
\n
devon@endoluxe.com<\/a>
310-529-5767\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Endoluxe today announced it has joined NVIDIA Inception, a program designed to support startups revolutionizing industries with artificial intelligence. Endoluxe\u2019s first product \u2014 used in minimally invasive surgery \u2014 is a completely wireless endoscopic camera system platform with an onboard light source. The Endoluxe Vision system leverages powerful hardware at the edge … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50067","6":"format-standard","7":"category-industry"},"yoast_head":"\nEndoluxe Joins NVIDIA Inception - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Endoluxe Joins NVIDIA Inception - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Endoluxe today announced it has joined NVIDIA Inception, a program designed to support startups revolutionizing industries with artificial intelligence. Endoluxe\u2019s first product \u2014 used in minimally invasive surgery \u2014 is a completely wireless endoscopic camera system platform with an onboard light source. The Endoluxe Vision system leverages powerful hardware at the edge ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-25T20:01:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221025006079\/en\/1613797\/21\/Endoluxe_Logo_BusinessWire-01.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Endoluxe Joins NVIDIA Inception\",\"datePublished\":\"2022-10-25T20:01:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/\"},\"wordCount\":445,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025006079\\\/en\\\/1613797\\\/21\\\/Endoluxe_Logo_BusinessWire-01.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/\",\"name\":\"Endoluxe Joins NVIDIA Inception - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025006079\\\/en\\\/1613797\\\/21\\\/Endoluxe_Logo_BusinessWire-01.jpg\",\"datePublished\":\"2022-10-25T20:01:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025006079\\\/en\\\/1613797\\\/21\\\/Endoluxe_Logo_BusinessWire-01.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221025006079\\\/en\\\/1613797\\\/21\\\/Endoluxe_Logo_BusinessWire-01.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/endoluxe-joins-nvidia-inception\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Endoluxe Joins NVIDIA Inception\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Endoluxe Joins NVIDIA Inception - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/","og_locale":"en_US","og_type":"article","og_title":"Endoluxe Joins NVIDIA Inception - Pharma Trend","og_description":"MANHATTAN BEACH, Calif.–(BUSINESS WIRE)–Endoluxe today announced it has joined NVIDIA Inception, a program designed to support startups revolutionizing industries with artificial intelligence. Endoluxe\u2019s first product \u2014 used in minimally invasive surgery \u2014 is a completely wireless endoscopic camera system platform with an onboard light source. The Endoluxe Vision system leverages powerful hardware at the edge ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-25T20:01:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221025006079\/en\/1613797\/21\/Endoluxe_Logo_BusinessWire-01.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Endoluxe Joins NVIDIA Inception","datePublished":"2022-10-25T20:01:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/"},"wordCount":445,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221025006079\/en\/1613797\/21\/Endoluxe_Logo_BusinessWire-01.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/","url":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/","name":"Endoluxe Joins NVIDIA Inception - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221025006079\/en\/1613797\/21\/Endoluxe_Logo_BusinessWire-01.jpg","datePublished":"2022-10-25T20:01:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221025006079\/en\/1613797\/21\/Endoluxe_Logo_BusinessWire-01.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221025006079\/en\/1613797\/21\/Endoluxe_Logo_BusinessWire-01.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/endoluxe-joins-nvidia-inception\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Endoluxe Joins NVIDIA Inception"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50067","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50067"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50067\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50067"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50067"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50067"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}